🔎 Trials Near Me

Home › Pangangalaga sa Mata

Pag-aaral pangklinika para sa Pangangalaga sa Mata na nagre-recruit sa U.S.

23 pag-aaral para sa Pangangalaga sa Mata ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

Screening for Research Participants

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00655096

A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)

Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07408232

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Nagre-recruitPhase 3
Edad 50 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07482176

Natural History, Pathogenesis, and Outcome of Ocular Disorders

Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT02821767

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care

Nagre-recruit
0 Days – 9 Months · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07738874

SGLT2 Inhibitors in Geographic Atrophy

Nagre-recruitPhase 2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07174687

Adaptive Optics Retinal Imaging

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT02317328

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Nagre-recruitPhase 2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07630649

APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes

Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07434635

Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye

Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT07413172

Ocular Blood Flow Imaging for Glaucoma Assessment

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 88 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05726058

Stem Cell Ophthalmology Treatment Study II

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT03011541

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06891443

A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness

Nagre-recruit
Edad 19 hanggang 70 · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT04634383

Strategies for Improving Linkage-to-Care After Eye Disease Screening

Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT06943599

RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT07322302

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
1 Month · Lahat ng kasarian · Na-update Mar 25, 2026 · NCT06841575

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06911424

Assessment of the Ocular Microbiome in Health and Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT05414994

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06934577

Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work

Nagre-recruitPhase 4
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Dis 5, 2025 · NCT07266948

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2025 · NCT06112340

IRIS Registry: Intelligent Research in Sight Registry

Nagre-recruitObservasyonal na pag-aaral
6 Months · Lahat ng kasarian · Na-update Hul 12, 2016 · NCT02485847

Mula sa ClinicalTrials.gov, na-kuha noong Okt 2, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.